Amgen (NASDAQ:AMGN) reported Q1 EPS of $4.25, $0.15 better than the analyst estimate of $4.10. Revenue for the quarter came in at $6.2 billion versus the consensus estimate of $6.07 billion.
GUIDANCE:
Amgen sees FY2022 EPS of $17.00-$18.00, versus the consensus of $17.63. Amgen sees FY2022 revenue of $25.4-26.5 billion, versus the consensus of $26.14 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.